Playback speed
10 seconds
Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study
By
2023 Conference Coverage
FEATURING
Friedemann Paul
By
2023 Conference Coverage
FEATURING
Friedemann Paul
80 views
May 23, 2023
Login to view comments.
Click here to Login